Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Free Cash Flow (2023 - 2025)

Historic Free Cash Flow for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$21.3 million.

  • Metagenomi's Free Cash Flow rose 2338.89% to -$21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$92.4 million, marking a year-over-year increase of 1432.82%. This contributed to the annual value of -$112.2 million for FY2024, which is 1083.15% down from last year.
  • As of Q3 2025, Metagenomi's Free Cash Flow stood at -$21.3 million, which was up 2338.89% from -$21.4 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Free Cash Flow ranged from a high of -$21.3 million in Q3 2025 and a low of -$30.8 million during Q1 2024
  • Moreover, its 3-year median value for Free Cash Flow was -$26.0 million (2023), whereas its average is -$25.4 million.
  • Per our database at Business Quant, Metagenomi's Free Cash Flow plummeted by 3001.31% in 2024 and then surged by 2481.72% in 2025.
  • Metagenomi's Free Cash Flow (Quarter) stood at -$22.3 million in 2023, then dropped by 19.17% to -$26.6 million in 2024, then grew by 19.85% to -$21.3 million in 2025.
  • Its last three reported values are -$21.3 million in Q3 2025, -$21.4 million for Q2 2025, and -$23.1 million during Q1 2025.